These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38379219)

  • 21. Long noncoding RNA DGCR5 involves in tumorigenesis of esophageal squamous cell carcinoma via SRSF1-mediated alternative splicing of Mcl-1.
    Duan Y; Jia Y; Wang J; Liu T; Cheng Z; Sang M; Lv W; Qin J; Liu L
    Cell Death Dis; 2021 Jun; 12(6):587. PubMed ID: 34099633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downregulated Long Noncoding RNA DGCR5 Acts as a New Promising Biomarker for the Diagnosis and Prognosis of Ovarian Cancer.
    Chen H; Tian X; Luan Y; Lu H
    Technol Cancer Res Treat; 2019; 18():1533033819896809. PubMed ID: 31868103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Propofol exerts anticancer activity on hepatocellular carcinoma cells by raising lncRNA DGCR5.
    Sun Y; Sun H
    J Cell Physiol; 2020 Mar; 235(3):2963-2972. PubMed ID: 31538334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer.
    Mouraviev V; Lee B; Patel V; Albala D; Johansen TE; Partin A; Ross A; Perera RJ
    Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):14-20. PubMed ID: 26503110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LncRNA DGCR5 contributes to CSC-like properties via modulating miR-330-5p/CD44 in NSCLC.
    Wang R; Dong HX; Zeng J; Pan J; Jin XY
    J Cell Physiol; 2018 Sep; 233(9):7447-7456. PubMed ID: 29663359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long non-coding RNA DGCR5 incudes tumorigenesis of triple-negative breast cancer by affecting Wnt/β-catenin signaling pathway.
    Jiang D; Wang C; He J
    J BUON; 2020; 25(2):702-708. PubMed ID: 32521856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA DGCR5 Silencing Enhances the Radio-Sensitivity of Human Esophageal Squamous Cell Carcinoma via Negatively Regulating the Warburg Effect.
    Wu J; Liu Y; Huang X; Cheng Y; Qian Z; Ni X; Chen S; Lin M; Luo J
    Radiat Res; 2023 Mar; 199(3):264-272. PubMed ID: 36730936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Wnt-induced lncRNA-DGCR5 splicing switch drives tumor-promoting inflammation in esophageal squamous cell carcinoma.
    Li Y; Chen B; Jiang X; Li Y; Wang X; Huang S; Wu X; Xiao Y; Shi D; Huang X; He L; Chen X; Ouyang Y; Li J; Song L; Lin C
    Cell Rep; 2023 Jun; 42(6):112542. PubMed ID: 37210725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormal expression of long non-coding RNAs RMRP, CTC-487M23.5, and DGCR5 in the peripheral blood of patients with Bipolar disorder.
    Ghamari M; Mehrab Mohseni M; Taheri M; Neishabouri SM; Shirvani-Farsani Z
    Metab Brain Dis; 2024 Feb; 39(2):313-320. PubMed ID: 37962788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LncRNA DGCR5/miR-204-5p/SRSF7 axis regulates PDGF-BB-induced proliferation and migration of airway smooth muscle cells with potential role in asthma.
    Zhou T; Chen X; Feng X
    Autoimmunity; 2023 Dec; 56(1):2193678. PubMed ID: 37066515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DGCR5 is activated by PAX5 and promotes pancreatic cancer via targeting miR-3163/TOP2A and activating Wnt/β-catenin pathway.
    Liu SL; Cai C; Yang ZY; Wu ZY; Wu XS; Wang XF; Dong P; Gong W
    Int J Biol Sci; 2021; 17(2):498-513. PubMed ID: 33613108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long noncoding RNAs: emerging regulators of tumor angiogenesis.
    Sheng SR; Wu JS; Tang YL; Liang XH
    Future Oncol; 2017 Jul; 13(17):1551-1562. PubMed ID: 28513194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DGCR5 attenuates neuropathic pain through sponging miR-330-3p and regulating PDCD4 in CCI rat models.
    Peng C; Zhang C; Su Z; Lin D
    J Cell Physiol; 2019 May; 234(5):7292-7300. PubMed ID: 30317600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. lncRNA DGCR5 acts as a tumor suppressor in papillary thyroid carcinoma via sequestering miR-2861.
    Chen F; Yin S; Zhu J; Liu P; Yang C; Feng Z; Deng Z
    Exp Ther Med; 2019 Jan; 17(1):895-900. PubMed ID: 30651878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long noncoding RNA in prostate, bladder, and kidney cancer.
    Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA
    Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of aberrant expression of LncRNA DGCR5/miR-873-5p/TUSC3 in lung cancer cell progression.
    Luo J; Zhu H; Jiang H; Cui Y; Wang M; Ni X; Ma C
    Cancer Med; 2018 Jul; 7(7):3331-3341. PubMed ID: 29790668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methods for the Study of Long Noncoding RNA in Cancer Cell Signaling.
    Feng Y; Jiang J; Hu Z; Yuan J; Zhang T; Pan Y; Xu M; Li C; Zhang Y; Zhang L; Hu X
    Methods Mol Biol; 2021; 2174():89-118. PubMed ID: 32813246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long noncoding RNAs in digestive system cancers: Functional roles, molecular mechanisms, and clinical implications (Review).
    Fu M; Zou C; Pan L; Liang W; Qian H; Xu W; Jiang P; Zhang X
    Oncol Rep; 2016 Sep; 36(3):1207-18. PubMed ID: 27431376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Clinical Utility of lncRNAs and Their Application as Molecular Biomarkers in Breast Cancer.
    Arriaga-Canon C; Contreras-Espinosa L; Aguilar-Villanueva S; Bargalló-Rocha E; García-Gordillo JA; Cabrera-Galeana P; Castro-Hernández C; Jiménez-Trejo F; Herrera LA
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LncRNAs and neoplasia.
    Isin M; Dalay N
    Clin Chim Acta; 2015 Apr; 444():280-8. PubMed ID: 25748036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.